LC-MS quantification and pharmacokinetics of the multi-constituents of huangqin tang in rat plasma after different single oral doses

Yaoxue Xuebao

Volumn 48, Issue 6, 2013, Pages 917-924

  Li, Tao ^a   Wang, Yi Wei ^a   Wang, Yan Li ^a   Liang, Ri Xin ^a   Zhang, Dong ^a   Zhang, Hui Hui ^a   Chen, Li ^a   Zhou, Zhong Ming ^a   Yang, Wei Peng ^a  

^a China Academy of Chinese Medicine   (China)

Author keywords

Flavonoids; Huangqin Tang; Pharmacokinetics; Terpenoids

Indexed keywords

BAICALEIN; BAICALIN; CHINESE DRUG; FLAVONOID; GLYCYRRHETINIC ACID; GLYCYRRHIZIC ACID; HUANGQIN TANG; HYDROCHLORIC ACID; OROXYLIN A; TERPENOID; UNCLASSIFIED DRUG; WOGONIN; WOGONOSIDE; 5,7-DIHYDROXY-6-METHOXY-2-PHENYLCHROMEN-4-ONE; FLAVANONE DERIVATIVE; GLUCOSIDE; HERBACEOUS AGENT; HUANGQIN-TANG; PAEONIFLORIN; PENTACYCLIC TRITERPENE; TERPENE;

ACCURACY; ARTICLE; DRUG BLOOD LEVEL; DRUG STABILITY; ELECTROSPRAY; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; RAT; SINGLE DRUG DOSE; ANIMAL; BLOOD; CHEMISTRY; DOSE RESPONSE; ELECTROSPRAY MASS SPECTROMETRY; MALE; ORAL DRUG ADMINISTRATION; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; CHROMATOGRAPHY, LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FLAVANONES; FLAVONOIDS; GLUCOSIDES; GLYCYRRHETINIC ACID; GLYCYRRHIZIC ACID; MALE; MONOTERPENES; PENTACYCLIC TRITERPENES; RATS; RATS, WISTAR; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84882385828     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Huang L, Ye WH, Cai BW, et al. A preliminary study on the pharmacology of the compound prescription Huangqin Tang and its component drugs [J], China J Chin Mater Med, 1990, 15:51-53.
2. Zhang B, Liang X, Liu Q. Modem pharmacodynamics research and clinic application of Huangqintang [J]. China J Chin Mater Med, 2008, 33:2587-2590.
3. Liu SH, Cheng YC. Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy [J], J Ethnopharmacol, 2012, 140:614-623.
4. Li C, Lin G, Zuo Z. Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones [J]. Biopharm Drug Dispos, 2011, 32:427-445.
5. Li-Weber M. New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents wogonin, baicalein and baicalin [J]. Cancer Treat Rev, 2009, 35:57-68.
6. Asl MN, Hosseinzadeh H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds [J], Phytother Res, 2008, 22:709-724.
7. Wu SH, Wu DG, Chen YW. Chemical constituents and bioactivities of plants from the Genus Paeonia [J], Chem Biodivers, 2010, 7:90-104.
8. Yu BT, Zhang ZR, Liu WS, et al. Studies on stability of baicalin [J], Chin Tradit Herb Drugs, 2002, 33:218-220.
9. Yao YH, Zhang LW. Study on stability of baicalein [J], Chin J Spectrosc Lab, 2006, 23:346-348.
10. Zuo F, Zhou ZM, Zhang Q, et al. Pharmacokinetic study on the multi-constituents of Huangqin-Tang decoction in rats [J], Biol Pharm Bull, 2003, 26:911-919.
11. Yan JC, Liu ZM, Wang TM, et al. Pharmacokinetics of flavonoids from Xiexin decoction in rats [J]. Acta Pharm Sin, 2007, 42:722-729.
12. Wang Y, Ding C, Wu C, et al. HPLC-MS and HPLC-MS/MS analysis of seven active constituents of Xiao-Xu-Ming decoction and application to a pharmacokinetic study after oral administration to rat [J], Acta Pharm Sin B, 2012, 2:188-197.
13. Guo XY, Yang L, Chen Y, et al. Comparison of pharmacokinetics of baicalein and baicalin in rats [J]. Chin Pharm J, 2008, 43:524-526.
14. Lu T, Song J, Huang F, et al. Comparative pharmacokinetics of baicalin after oral administration of pure baicalin, Radix Scutellariae extract and Huang-Lian-Jie-Du-Tang to rats [J], J Ethnopharmacol, 2007, 110:412-418.
15. Xing J, Chen X, Zhong D. Absorption and enterohepatic circulation of baicalin in rats [J]. Life Sci, 2005, 78:140-146.
16. Takeda S, Ishihara K, Wakui Y, et al. Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis [J], J Pharm Pharmacol, 1996, 48:902-905.
17. Ploeger BA, Meulenbelt J, DeJongh J. Physiologically based pharmacokinetic modeling of glycyrrhizic acid, a compound subject to presystemic metabolism and enterohepatic cycling [J]. Toxicol Appl Pharmacol, 2000, 162:177-188.
18. Zuo F, Zhou ZM, Liu ML. Determination of 14 chemical constituents in the traditional Chinese medicinal preparation Huangqin-Tang by high performance liquid chromatography [J], Biol Pharm Bull, 2001, 24:693-697.
19. Zhang X, Li Z, Leung W, et al. The analgesic effect of paeoniflorin on neonatal maternal separation-induced visceral hyperalgesia in rats [J]. J Pain, 2008, 9:497-505.
20. Che QM, Yang L, Chen Y, et al. Comparison of pharmacokinetics between different doses of baicalein in rats [J], Chin J New Drugs, 2007, 16:604-606.
21. Di B, Feng N, Liu W. Pharmacokinetic comparisons of Shuang-Huang-Lian with the different combinations of its constitutional herbs [J]. J Ethnopharmacol, 2006, 107:401-405.
22. Huang P, JW G, Zou J, et al. Effects of different Dahuang Huanglian Xiexin decoction formulations on the pharmacokinetics of baicalin and wogonoside in rats [J], World Sci Technol Mod Tradit Chin Med Mater Med, 2012, 14:1445-1450.
23. Li CR, Zhang L, Wo SK, et al. Pharmacokinetic interactions among major bioactive components in Radix Scutellariae via metabolic competition [J]. Biopharm Drug Dispos, 2012, 33:487-500.
24. Feng NP, Di B, Liu WY. Comparison of the metabolism of baicalin in rats orally administered with Radix Scutellariae extract and Shuang-Huang-Lian extract [J], Chem Pharm Bull, 2005, 53:978-983.
25. Chen BL, Li SL, Li P, et al. The uptake characteristics of flavonoids in Caco-2 model system [J]. Chin J Nat Med, 2006, 4:299-302.
26. Tian XJ, Yang XW, Yang X, et al. Studies of intestinal permeability of 36 flavonoids using Caco-2 cell monolayer model [J], Int J Pharm, 2009, 367:58-64.
27. Dai J, Yang J, Li C. Transport and metabolism of flavonoids from Chinese herbal remedy Xiaochaihu-tang across human intestinal Caco-2 cell monolayersl [J]. Acta Pharmacol Sin, 2008, 29:1086-1093.
28. Zhang L, Lin G, Kovács B, et al. Mechanistic study on the intestinal absorption and disposition of baicalein [J]. Eur J Pharm Sci, 2007, 31:221-231.
29. Li C, Zhang L, Zhou L, et al. Comparison of intestinal absorption and disposition of structurally similar bioactive flavones in Radix Scutellariae [J], AAPS J, 2012, 14:23-33.
30. Lu T, Yang J, Gao X, et al. Plasma and urinary tanshinol from Salvia milliorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine [J]. DrugMetab Dispos, 2008, 36:1578-1586.
31. Liu H, Yang J, Du F, et al. Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats [J]. Drug Metab Dispos, 2009, 37:2290-2298.
32. Li T, Wang YW, Wang YL, et al. Development of an SPE-HPLC-MS method for simultaneous determination and pharmacokinetic study of bioactive constituents of Yu Ping Feng San in rat plasma after oral administration [J]. J Ethnopharmacol, 2013, 145:784-792.